Grant: Operating Grant
McMaster University
$219,144.00
Determining the optimum treatment cutoffs for high-sensitivity troponin assays in patients presenting to the emergency department with suspected cardiac ischemia
EF 2012-13
Résumé
Cardiac troponin is a protein released from heart cells into the blood just prior to and during a heart attack. Hence, increased troponin levels in the blood are used to make or confirm the diagnosis of a heart attack in patients who go to the emergency department (ED) with chest pain. Within the next year, Canadian hospitals will begin to use newer troponin blood tests that can detect lower levels than the current ones. The problem is that no one knows what levels of the new tests best diagnose a heart attack. Also, there is evidence that the troponin levels can even predict which patients are at greatest or least risk of a heart attack or other serious heart problem within the next week, month or 6 months but, again, we don't know what these levels are.
We propose to recruit 1887 patients who come to the ED with chest pain or other symptoms of a heart attack and perform the newer blood test when they arrive and 3 hours later. Without interfering in their care, we will then follow these patients to determine if any of them had a heart attack or other serious heart problem within the first week, first month and six months after their ED visit. This information will allow us to determine what troponin levels best identify patients at the highest risk for a heart problem early (within the first week) and which patients would benefit from hospital admission and treatment for their disease. We will also be able to determine what levels are the best for identifying patients at the highest risk for a heart problem at 30 days and 6 months.
In short, the results of this study will enable physicians to identify patients who are not currently recognized as being at high risk for a serious heart problem and treat them appropriately while also avoiding hospital admission and treatment of patients who could be managed equally well as outpatients. Thus, this study has the potential to improve patient health and safety while also reducing hospital costs and ED overcrowding.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
266666
Name
Worster Andrew
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Public, Community & Population Health
Projecttitle
Determining the optimum treatment cutoffs for high-sensitivity troponin assays in patients presenting to the emergency department with suspected cardiac ischemia
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$219,144
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cardiac Troponin Assays; Cardiovascular Events; Emergency Medicine; Prognosis
Abstract
Cardiac troponin is a protein released from heart cells into the blood just prior to and during a heart attack. Hence, increased troponin levels in the blood are used to make or confirm the diagnosis of a heart attack in patients who go to the emergency department (ED) with chest pain. Within the next year, Canadian hospitals will begin to use newer troponin blood tests that can detect lower levels than the current ones. The problem is that no one knows what levels of the new tests best diagnose a heart attack. Also, there is evidence that the troponin levels can even predict which patients are at greatest or least risk of a heart attack or other serious heart problem within the next week, month or 6 months but, again, we don't know what these levels are.
We propose to recruit 1887 patients who come to the ED with chest pain or other symptoms of a heart attack and perform the newer blood test when they arrive and 3 hours later. Without interfering in their care, we will then follow these patients to determine if any of them had a heart attack or other serious heart problem within the first week, first month and six months after their ED visit. This information will allow us to determine what troponin levels best identify patients at the highest risk for a heart problem early (within the first week) and which patients would benefit from hospital admission and treatment for their disease. We will also be able to determine what levels are the best for identifying patients at the highest risk for a heart problem at 30 days and 6 months.
In short, the results of this study will enable physicians to identify patients who are not currently recognized as being at high risk for a serious heart problem and treat them appropriately while also avoiding hospital admission and treatment of patients who could be managed equally well as outpatients. Thus, this study has the potential to improve patient health and safety while also reducing hospital costs and ED overcrowding.
Competitiondate
201209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Worster, Andrew; Kavsak, Peter A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $219,144~ $0~